IRCT20091012002582N20招募中1 期
Effect of prothrombin Concentrate complex on reverse of bleeding due to Rivaroxaban in critically ill patients admitted to intensive care unit
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •All patients who admitted in ICU with major bleeding and Life threatening related to Rivaroxaban
排除标准
- •Unwillingness of the patient
- •Allergic to PCC
- •History of receiving antiplatelet drugs&NSAIDs
研究者
相似试验
已完成
不适用
Efficacy of prothrombin complex concentrate in intracranial hemorrhage patients under anticoagulant therapyIntracranial hemorrhageJPRN-UMIN000021066Kyoto Prefectural University of Medicine15
已完成
3 期
A Randomised Controlled Trial to Compare Administration of Prothrombin Complex Concentrate with Standard Haemostasis Management in Adult Patients Undergoing Peritoneal Cytoreductive Surgery Requiring Massive Transfusion.Patients undergoing peritoneal cytoreductive surgeryPeritoneal cancerSurgery - Other surgeryCancer - Ovarian and primary peritonealACTRN12612001002875St George Hospital80
已完成
4 期
Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation.Bleedinghemorrhage10064477NL-OMON40112niversitair Medisch Centrum Groningen60
进行中（未招募）
1 期
Study to demonstrate the efficacy and safety of OCTAPLEX in patients with acute major bleeding that are taking direct oral anticoagulant.Acute major bleeding in patients receiving DOAC therapy with factor Xa inhibitorMedDRA version: 20.0Level: LLTClassification code 10009731Term: Coagulation disorderSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2021-000740-21-ATOctapharma AG260
进行中（未招募）
1 期
Study to demonstrate the efficacy and safety of OCTAPLEX in patients with acute major bleeding that are taking direct oral anticoagulant.EUCTR2021-000740-21-ITOCTAPHARMA AG200